| |
| |
|
| Insider
Information: |
Schuler Jack W |
| Relationship: |
|
| City: |
Lake Forest |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
27,956,178 |
|
|
Indirect Shares
|
61,134,751 |
|
|
| Direct
Value |
$198,559,401 |
|
|
|
Indirect Value
|
$175,231,488 |
|
|
| Total
Shares |
89,090,929 |
|
|
| Total
Value |
$373,790,889 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
54
|
96
|
|
Stock
price went up :
|
14
|
2
|
| Stock
price went down : |
40
|
94
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -25.7%
|
-5,816.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stericycle Inc |
SRCL |
Director |
2018-03-01 |
626,142 |
2018-03-01 |
56,460 |
Premium* |
|
|
Ventana Medical Systems Inc |
VMSI |
Director |
2008-02-08 |
0 |
2008-02-11 |
0 |
Premium* |
|
|
QuidelOrtho Corporation |
QDEL |
Director, 10% Owner |
2020-05-14 |
3,103,249 |
2018-01-22 |
3,414,053 |
Premium* |
|
|
Oncternal Therapeutics Inc |
ONCT |
10% Owner |
2014-03-21 |
6,165,261 |
2010-12-14 |
21,500 |
Premium* |
|
|
Transition Therapeutics |
TTHI |
10% Owner |
2011-11-22 |
2,823,010 |
2011-11-22 |
0 |
Premium* |
|
|
Yield10 Bioscience Inc |
YTEN |
|
2015-06-19 |
2,185,652 |
2023-12-20 |
63,789 |
Premium* |
|
|
Accelr8 Technology Corp |
AXDX |
Director, 10% Owner |
2024-05-29 |
15,488 |
2024-05-29 |
8,515,885 |
Premium* |
|
|
Aspira Womens Health Inc |
AWH |
|
2017-08-31 |
6,673,029 |
2023-07-24 |
1,883,656 |
Premium* |
|
|
Hansen Medical Inc |
HNSN |
Director |
2014-02-26 |
5,319,769 |
2014-02-26 |
13,249,640 |
Premium* |
|
|
Biolase Inc |
BIOL |
|
|
0 |
2020-02-11 |
759,820 |
Premium* |
|
|
Neos Therapeutics, Inc. |
NEOS |
10% Owner |
2015-07-28 |
1,044,578 |
2017-02-17 |
2,338,671 |
Premium* |
|
|
Soleno Therapeutics Inc |
SLNO |
|
2018-12-21 |
0 |
2022-12-09 |
36,595 |
Premium* |
|
|
Biodesix Inc |
BDSX |
|
2020-10-30 |
0 |
2024-05-23 |
30,794,682 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
634 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 9 of 26
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2020-04-14 |
4 |
GD |
$0.00 |
$0 |
I/I |
1,100,000 |
1,077,023 |
0 |
- |
|
| VMSI |
Ventana Medical Systems I... |
Director |
– • – |
2003-12-16 |
4 |
OE |
$12.63 |
$883,750 |
D/D |
70,000 |
1,091,664 |
|
- |
|
| VMSI |
Ventana Medical Systems I... |
Director |
– • – |
2004-12-14 |
5 |
GD |
$0.00 |
$0 |
D/D |
13,700 |
1,101,675 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2021-01-29 |
4 |
B |
$10.18 |
$314,236 |
I/I |
30,868 |
1,107,891 |
2.25 |
% |
|
| VMSI |
Ventana Medical Systems I... |
Director |
– • – |
2004-12-09 |
4 |
D |
$59.80 |
$358,142 |
D/D |
(5,989) |
1,115,375 |
|
- |
|
| VMSI |
Ventana Medical Systems I... |
Director |
– • – |
2004-12-09 |
4 |
OE |
$10.13 |
$358,213 |
D/D |
29,700 |
1,121,364 |
|
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2021-02-01 |
4 |
A |
$11.40 |
$1,140,000 |
I/I |
100,000 |
1,207,891 |
0 |
- |
|
| VMSI |
Ventana Medical Systems I... |
Director |
– • – |
2006-12-19 |
4 |
D |
$42.30 |
$853,699 |
D/D |
(20,182) |
1,224,193 |
0 |
- |
|
| VMSI |
Ventana Medical Systems I... |
Director |
– • – |
2006-12-20 |
4 |
D |
$42.42 |
$134,047 |
D/D |
(3,160) |
1,236,033 |
0 |
- |
|
| VMSI |
Ventana Medical Systems I... |
Director |
– • – |
2006-12-20 |
4 |
OE |
$8.94 |
$134,070 |
D/D |
15,000 |
1,239,193 |
0 |
- |
|
| VMSI |
Ventana Medical Systems I... |
Director |
– • – |
2006-12-19 |
4 |
OE |
$6.31 |
$853,752 |
D/D |
129,000 |
1,244,375 |
0 |
- |
|
| NEOS |
Neos Therapeutics, Inc. |
10% Owner |
– – • |
2015-07-28 |
4 |
A |
$0.00 |
$0 |
I/I |
208,325 |
1,252,903 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2021-02-02 |
4 |
A |
$9.87 |
$534,283 |
I/I |
54,132 |
1,262,023 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2019-11-13 |
4 |
A |
$16.04 |
$80,200 |
I/I |
5,000 |
1,267,023 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2012-12-07 |
5 |
GD |
$0.00 |
$0 |
D/D |
100,000 |
1,275,104 |
0 |
- |
|
| NEOS |
Neos Therapeutics, Inc. |
10% Owner |
– – • |
2015-07-28 |
4 |
B |
$15.00 |
$300,000 |
I/I |
20,000 |
1,279,903 |
1.5 |
- |
|
| AWH |
Aspira Womens Health Inc |
10% Owner |
– – • |
2014-12-23 |
4 |
B |
$1.44 |
$1,855,208 |
I/I |
1,288,339 |
1,288,339 |
1.5 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2012-12-14 |
4 |
S |
$93.31 |
$2,796,781 |
D/D |
(29,973) |
1,291,916 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2017-11-06 |
4 |
B |
$18.51 |
$6,311,293 |
I/I |
340,964 |
1,293,642 |
2.25 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2012-12-13 |
4 |
S |
$93.38 |
$8,016,953 |
D/D |
(85,853) |
1,321,889 |
0 |
- |
|
| AXDX |
Accelr8 Technology Corp |
Director |
– • • |
2017-11-07 |
4 |
B |
$18.73 |
$936,500 |
I/I |
50,000 |
1,343,642 |
2.25 |
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2012-11-26 |
5 |
GD |
$0.00 |
$0 |
D/D |
3,124 |
1,375,104 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Chairman |
• • – |
2003-07-14 |
4 |
D |
$46.00 |
$350,014 |
D/D |
(7,609) |
1,375,457 |
|
- |
|
| SRCL |
Stericycle Inc |
Director |
– • – |
2012-11-13 |
5 |
GD |
$0.00 |
$0 |
D/D |
10,800 |
1,378,228 |
0 |
- |
|
| SRCL |
Stericycle Inc |
Chairman |
• • – |
2003-07-14 |
4 |
OE |
$7.25 |
$350,021 |
D/D |
44,436 |
1,378,718 |
|
- |
|
634 Records found
|
|
Page 9 of 26 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
